المؤلفون: Ban, Marija, Strikić, Ante, Petrić Miše, Branka, Vrdoljak, Eduard

المصدر: Liječnički vjesnik
Volume 141
Issue 1-2

مصطلحات موضوعية: TUMORI DOJKE – farmakoterapija, metabolizam, patologija, smrtnost, HORMONSKI OVISNI TUMORI – farmakoterapija, metabolizam, patologija, smrtnost, PROTUTUMORSKI LIJEKOVI – farmakologija, neželjeni učinci, terapijska primjena, RECEPTOR ERBB-2 – metabolizam, CIKLIN OVISNA KINAZA 4 – antagonisti i inhibitori, metabolizam, CIKLIN OVISNA KINAZA 6 – antagonisti i inhibitori, metabolizam, AROMATOZNI INHIBITORI – terapijska primjena, FULVESTRANT – terapijska primjena, INHIBITORI PROTEINSKE KINAZE – neželjeni učinci, terapijska primjena, TUMORSKE METASTAZE, PREŽIVLJENJE BEZ PROGRESIJE BOLESTI, tumori dojke, hormonski ovisni tumori, protutumorski lijekovi, receptor erbb-2, ciklin ovisna kinaza 4, ciklin ovisna kinaza 6, aromatozni inhibitori, fulvestrant, inhibitori proteinske kinaze, tumorske metastaze, preživljenje bez progresije bolesti, BREAST NEOPLASMS – drug therapy, metabolism, mortality, pathology, NEOPLASMS, HORMONE-DEPENDENT – drug therapy, metabolism, mortality, pathology, ANTINEOPLASTIC AGENTS – adverse effects, pharmacology, therapeutic use, RECEPTOR, ERBB-2 – metabolism, CYCLIN-DEPENDENT KINASE 4 – antagonists and inhibitors, metabolism, CYCLIN-DEPENDENT KINASE 6 – antagonists and inhibitors, metabolism, AROMATOZNI INHIBITORI – therapeutic use, FULVESTRANT – therapeutic use, PROTEIN KINASE INHIBITORS – adverse effects, therapeutic use, NEOPLASM METASTASIS, PROGRESSION-FREE SURVIVAL

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4248c2d4b83c409d59a559a9890c027e
https://hrcak.srce.hr/218766

Additional Titles: Role of CDK4/6 inhibitors in metastatic hormon positive HER2 negative breast cancer treatment

المؤلفون: Marija Ban, Ante Strikić, Branka Petrić Miše, Eduard Vrdoljak

المصدر: Liječnički vjesnik; ISSN 0024-3477 (Print); ISSN 1849-2177 (Online); Volume 141; Issue 1-2

مصطلحات الفهرس: TUMORI DOJKE – farmakoterapija, metabolizam, patologija, smrtnost; HORMONSKI OVISNI TUMORI – farmakoterapija, metabolizam, patologija, smrtnost; PROTUTUMORSKI LIJEKOVI – farmakologija, neželjeni učinci, terapijska primjena; RECEPTOR ERBB-2 – metabolizam; CIKLIN OVISNA KINAZA 4 – antagonisti i inhibitori, metabolizam; CIKLIN OVISNA KINAZA 6 – antagonisti i inhibitori, metabolizam; AROMATOZNI INHIBITORI – terapijska primjena; FULVESTRANT – terapijska primjena; INHIBITORI PROTEINSKE KINAZE – neželjeni učinci, terapijska primjena; TUMORSKE METASTAZE; PREŽIVLJENJE BEZ PROGRESIJE BOLESTI, BREAST NEOPLASMS – drug therapy, metabolism, mortality, pathology; NEOPLASMS, HORMONE-DEPENDENT – drug therapy, metabolism, mortality, pathology; ANTINEOPLASTIC AGENTS – adverse effects, pharmacology, therapeutic use; RECEPTOR, ERBB-2 – metabolism; CYCLIN-DEPENDENT KINASE 4 – antagonists and inhibitors, metabolism; CYCLIN-DEPENDENT KINASE 6 – antagonists and inhibitors, metabolism; AROMATOZNI INHIBITORI – therapeutic use; FULVESTRANT – therapeutic use; PROTEIN KINASE INHIBITORS – adverse effects, therapeutic use; NEOPLASM METASTASIS; PROGRESSION-FREE SURVIVAL, text, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://hrcak.srce.hr/218766
https://hrcak.srce.hr/file/319312
info:eu-repo/semantics/altIdentifier/doi/10.26800/LV-141-1-2-6